Profile data is unavailable for this security.
About the company
Haleon plc is a consumer healthcare company. The Company's product portfolio is divided among five categories: Oral Health; Pain Relief; vitamins, minerals and supplements (VMS); Respiratory Health; Digestive Health, and Other. Its portfolio of brands includes Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax and Centrum. In addition, the Company also has local strategic brands, which include TUMS, ENO, Flonase, ChapStick, Emergen-C, Fenbid, Grand-Pa, and Dr.BEST. The Company operates its business units in three regions: North America; Europe, Middle East, and Africa (EMEA) and Latin America (LatAm), and Asia-Pacific (APAC).
- Revenue in GBP (TTM)10.86bn
- Net income in GBP1.06bn
- Incorporated2021
- Employees21.00k
- LocationHaleon PLCBuilding 5, First Floor, The HeightsBRENTFORD KT13 0NYUnited KingdomGBR
- Phone+44 193 282 2000
- Websitehttps://www.haleon.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recordati Industria Chimica e Farma SpA | 1.63bn | 275.11m | 7.21bn | 4.30k | 26.09 | 5.21 | 18.69 | 4.42 | 1.50 | 1.50 | 8.90 | 7.52 | 0.5439 | 1.74 | 5.53 | -- | 9.17 | 12.82 | 11.86 | 16.38 | 69.42 | 71.05 | 16.85 | 22.48 | 0.8114 | 15.90 | 0.5261 | 61.84 | 17.29 | 7.55 | -19.08 | 1.58 | 45.87 | 6.23 |
| Ipsen SA | 2.78bn | 522.50m | 7.60bn | 5.74k | 15.29 | 2.55 | 9.24 | 2.74 | 6.74 | 7.32 | 34.75 | 40.45 | 0.5956 | 2.10 | 5.27 | -- | 11.20 | 9.91 | 14.78 | 13.80 | 83.28 | 82.00 | 18.81 | 15.23 | 1.58 | 47.09 | 0.1904 | 21.11 | 5.24 | 9.43 | -8.26 | 17.05 | 0.9854 | 3.71 |
| Qiagen NV | 1.74bn | 343.79m | 8.49bn | 6.18k | 24.91 | 3.01 | 16.56 | 4.88 | 1.70 | 1.70 | 8.58 | 14.04 | 0.3444 | 2.21 | 6.03 | 319,685.20 | 6.81 | 5.04 | 8.51 | 6.02 | 64.65 | 65.39 | 19.76 | 15.54 | 2.09 | 30.33 | 0.3494 | -- | -4.89 | 8.60 | -17.44 | -- | 3.72 | -- |
| Croda International Plc | 2.09bn | 649.30m | 9.07bn | 5.83k | 13.98 | 3.75 | 11.72 | 4.34 | 4.65 | 4.65 | 14.96 | 17.30 | 0.6051 | 2.43 | 5.85 | 358,678.10 | 18.92 | 12.85 | 22.04 | 15.05 | 47.17 | 45.61 | 31.27 | 20.16 | 1.43 | 23.80 | 0.2021 | 48.63 | 10.57 | 8.76 | 102.40 | 23.14 | -0.8817 | 5.41 |
| BioMerieux SA | 3.16bn | 398.48m | 10.27bn | 13.08k | 25.80 | 3.23 | 16.93 | 3.25 | 3.82 | 3.82 | 30.30 | 30.54 | 0.7331 | 2.33 | 5.39 | 274,480.00 | 9.00 | 9.87 | 11.57 | 13.16 | 55.97 | 56.21 | 12.27 | 12.94 | 1.31 | 136.56 | 0.1218 | 15.68 | 6.31 | 9.42 | -24.74 | 13.70 | 9.33 | 20.11 |
| Eurofins Scientific SE | 5.91bn | 579.75m | 10.44bn | 61.38k | 18.61 | 2.48 | 9.98 | 1.77 | 3.31 | 2.92 | 33.73 | 24.84 | 0.6914 | 34.68 | 4.92 | 109,355.00 | 7.04 | 7.70 | 8.71 | 9.70 | 22.54 | 23.80 | 10.18 | 11.58 | 1.22 | 8.08 | 0.4067 | 19.13 | -0.0834 | 17.70 | -34.73 | 20.14 | 21.85 | 33.03 |
| UCB SA | 4.86bn | 369.94m | 14.21bn | 8.70k | 38.44 | 1.73 | 15.97 | 2.92 | 2.16 | 2.15 | 28.69 | 47.81 | 0.3669 | 1.88 | 4.82 | 633,919.30 | 2.79 | 6.23 | 3.48 | 7.82 | 69.66 | 73.49 | 7.61 | 14.76 | 0.7702 | 9.12 | 0.2424 | 31.62 | -4.50 | 4.02 | -60.19 | -11.00 | 12.16 | 2.42 |
| argenx SE | 333.66m | -576.42m | 16.85bn | 843.00 | -- | 7.36 | -- | 50.49 | -12.08 | -12.08 | 7.01 | 46.84 | 0.1373 | 0.1744 | 2.94 | 449,360.00 | -23.71 | -21.60 | -26.37 | -24.30 | 92.83 | -- | -172.76 | -188.60 | 8.42 | -80.20 | 0.0044 | -- | -17.40 | 58.50 | -73.81 | -- | 204.62 | -- |
| Merck KGaA | 19.58bn | 2.93bn | 19.26bn | 64.23k | 22.15 | 2.88 | 4.26 | 0.9836 | 7.64 | 7.64 | 51.09 | 59.63 | 0.4736 | 2.00 | 5.49 | 346,120.30 | 7.11 | 5.14 | 9.05 | 6.72 | 61.65 | 62.61 | 15.02 | 11.92 | 0.7957 | 26.91 | 0.2856 | 9.64 | 12.93 | 8.90 | 8.87 | 5.47 | 6.62 | 11.97 |
| Genmab A/S | 1.73bn | 652.95m | 20.24bn | 1.66k | 30.98 | 6.18 | -- | 11.73 | 83.72 | 83.72 | 221.20 | 419.77 | 0.5317 | -- | 3.15 | 8,792,169.00 | 20.11 | 19.27 | 21.44 | 20.51 | -- | -- | 37.83 | 40.71 | -- | -- | 0.0213 | -- | 72.07 | 43.90 | 83.58 | 37.99 | 29.07 | -- |
| HALEON PLC | 10.86bn | 1.06bn | 29.87bn | 21.00k | 28.19 | 1.83 | -- | 2.75 | 0.1147 | 0.1147 | 1.18 | 1.77 | -- | -- | -- | 517,047.60 | -- | -- | -- | -- | 60.76 | -- | 10.31 | -- | 0.6204 | 11.10 | 0.3882 | -- | 13.76 | -- | -23.74 | -- | -- | -- |
| Lonza Group AG | 5.50bn | 1.07bn | 35.29bn | 17.49k | 32.80 | 3.76 | 22.02 | 6.41 | 16.34 | 16.34 | 83.69 | 142.66 | 0.3681 | 2.28 | 5.95 | 355,722.00 | 7.20 | 5.30 | 8.63 | 6.48 | 39.18 | 39.90 | 19.57 | 15.20 | 1.27 | 21.61 | 0.1731 | 28.41 | 15.05 | 6.47 | 80.27 | 12.84 | 32.93 | 4.94 |
Data as of Mar 30 2023. Currency figures normalised to Haleon PLC's reporting currency: UK Pound GBX
9.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dodge & Coxas of 31 Dec 2022 | 145.93m | 1.58% |
| The Vanguard Group, Inc.as of 03 Mar 2023 | 135.64m | 1.47% |
| Norges Bank Investment Managementas of 31 Dec 2022 | 119.24m | 1.29% |
| First Eagle Investment Management LLCas of 31 Jan 2023 | 113.48m | 1.23% |
| Franklin Mutual Advisers LLCas of 28 Feb 2023 | 96.53m | 1.05% |
| BlackRock Fund Advisorsas of 01 Mar 2023 | 85.87m | 0.93% |
| BlackRock Investment Management (UK) Ltd.as of 28 Feb 2023 | 67.37m | 0.73% |
| BlackRock Advisors (UK) Ltd.as of 01 Mar 2023 | 59.96m | 0.65% |
| Invesco Advisers, Inc.as of 02 Mar 2023 | 50.07m | 0.54% |
| TIAA-CREF Investment Management LLCas of 31 Jan 2023 | 47.48m | 0.51% |
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
